ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

Novo Nordisk launches once-weekly basal insulin 'Awiqli' in India as diabetes rates increase
Novo Nordisk has launched Awiqli, a new weekly basal insulin injection, in India. This innovative drug offers a once-weekly alternative to daily injections for diabetes patients. Awiqli aims to reduce barriers to insulin initiation, which is often delayed
Announcement as on 09 July 2026

Shantha Biologics to make injectable drug cartridges for Novo Nordisk
Shantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable medicines at its Hyderabad facility. This partnership highlights India's growing role in advanced pharmaceutical man
Announcement as on 02 July 2026

Novo Nordisk A/S Q1 Earnings Call Highlights
Hims & Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recovery?Novo Nordisk A/S (NYSE:NVO) said its first quarter of 2026 was marked by rapid uptake of its newly launched Wegovy pill in the U.S., continued expansion of its obesity fr
Announcement as on 13 May 2026

Novo Nordisk’s weight-loss drug patent loss sparks a ‘gold rush’ for generic drugmakers
India's weight-loss drug market is seeing a major shift. Generic versions of Novo Nordisk's semaglutide are now available at lower prices. This is impacting Eli Lilly's drug sales. The market is expected to grow significantly. Indian drugmakers are launchi
Announcement as on 09 April 2026

Lilly's weight-loss pill wins US approval, sets up next battle with rival Novo Nordisk
The US FDA has approved Eli Lilly's new weight-loss pill, Foundayo. This marks a significant step in the ongoing competition with rival Novo Nordisk in the GLP-1 medicine market. Foundayo is an oral medication offering a new option for weight management. L
Announcement as on 02 April 2026

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 39.85
  • 12Day Average: 41.82
  • 20Day Average: 43.51
  • 50Day Average: 46
  • 100Day Average: 45.99
  • 150Day Average: 43.57
  • 200Day Average: 46.04

NVO Indicators & signals

Indicator MACD (12,26,9)

41.48, 43.43, -1.37
Indicator MACD is in negative zone

Indicator ADX (14)

53.09, 13.29, 43.36
Indicator ADX is indicating that momentum is still strong.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 43
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
24 Thu Sep 2026 38.63 37.61 to 38.72 1.21% 0.99 times
23 Wed Sep 2026 38.17 38.16 to 39.14 -3.12% 1.25 times
22 Tue Sep 2026 39.40 39.11 to 39.89 -1.05% 1.66 times
21 Mon Sep 2026 39.82 39.54 to 43.72 -7.91% 2.78 times
18 Fri Sep 2026 43.24 42.78 to 43.54 0.12% 0.7 times
17 Thu Sep 2026 43.19 41.96 to 43.44 3.55% 0.88 times
16 Wed Sep 2026 41.71 41.47 to 42.72 -1.95% 0.79 times
15 Tue Sep 2026 42.54 42.40 to 43.53 -2.07% 0.42 times
14 Mon Sep 2026 43.44 42.81 to 43.74 0.86% 0.33 times
11 Fri Sep 2026 43.07 42.72 to 43.50 -2.14% 0.75 times
10 Thu Sep 2026 44.01 44.01 to 44.82 -1.23% 0.45 times
09 Wed Sep 2026 44.56 44.52 to 45.40 -1.33% 0.6 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

 

Back to top